Symbol
BRTX on Nasdaq
Investment type
Equity - Shares of Stock
Class
Common Stock, $0.0001 par value
Latest Disclosed Ownership
1.24M shares
Security Ownership
15.5%

ALSTODT LANCE ownership in BioRestorative Therapies, Inc. Common Stock, $0.0001 par value (BRTX)

2025-02-19 - ALSTODT LANCE has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1.24M shares of BioRestorative Therapies, Inc. Common Stock, $0.0001 par value (BRTX). This represents 15.5% percent ownership of the company.